When: Capitulation flush to $1,000-$1,040

Then: Entry on capitulation

Hold full position with tightened trailing stop; only trim on confirmed technical breakdown below lower Bollinger band at $1,085 or 200 SMA at $1,062; limit any trim to 10-15% for portfolio rebalancing only

• Q2 revenue $22.97 billion, up 47.7% YoY; Q2 operating income $12.46 billion, up 77% YoY from $7.02 billion
• EPS sequential dip to $7.94 from $8.26 explained by aggressive reinvestment: CapEx tripled YoY to $6.22B, R&D at $3.82B, acquisitions $8.75B in single quarter
• Beta 0.50 makes LLY a defensive name by construction; macro risks already priced in at 93% Polymarket no-cut consensus
• Inventory $16.79B, up 52% YoY, interpreted as capacity ramp to meet demand rather than write-down risk; PP&E increased from $20.5B to $29.3B YoY
• Current technical setup: price sitting just above long-term support with compressing ATR
• Recommended stop: daily close below lower Bollinger band at $1,085 (approximately 2.5% downside tolerance) or confirmed close below 200 SMA at $1,062
• Oppose trim above current levels ($1,180 bounce target); re-entry frameworks typically capture only 60-70% of momentum moves
• Market cap $1.07 trillion with 47% revenue growth rate supports maintaining full position

→ vs aggressive: Sequential EPS dip from $8.26 to $7.94 is noise, not signal; company reinvesting heavily into future growth with CapEx tripling YoY and $8.75B acquisitions in a single quarter, making premature selling a timing error

→ vs aggressive: Macro thesis (93% Polymarket no-cut pricing) is already consensus and fully reflected in the stock; LLY's 0.50 beta defensive characteristics make it suitable for hawkish regimes, not a candidate for trimming into them

→ vs neutral: HOLD is correct instinct but trailing stop at 200 SMA minus one ATR (~$1,062) is too loose; a 12% adverse move occurs before the stop triggers, which is waiting for damage to be done rather than managing risk

15% trim in tranches (7-8% now at $1,115.70, 7% on rally to $1,145 or $1,183) with $1,072 trailing stop and full exit on confirmed $1,062 close below 200 SMA; re-entry on flush to $1,000-$1,062 with RSI below 30 OR 50 SMA reclaim on expanding volume

• Aggressive plan to sell at $1,180 is a conditional trigger not yet actionable; price is $1,115.70, making the trim scenario hypothetical
• Q2 sequential EPS dip from $8.26 to $7.94 is noise during CapEx cycle that tripled to $6.22B and $8.75B acquisition spend; 77% YoY operating income jump ($12.46B vs $7.02B) and 47.7% revenue growth show reinvestment, not deterioration
• Conservative's 93% Polymarket no-cut pricing being 'fully priced' misses that a shift to 'hike' would be a new information event causing multiple compression independent of market beta
• Beta of 0.5 measures market correlation, not duration risk; LLY can lose 15% on multiple compression while tracking the market perfectly
• $16.79B inventory build plus $54.9B total debt creates meaningful operating leverage to revenue disappointment not reflected in the multiple
• Conservative's $1,085 lower Bollinger stop is too tight; LLY tested and closed near lower band multiple sessions in March 2026 before reversing, creating whipsaw risk
• 2.5% stop on ATR of $31.76 is less than one ATR of room, offering noise tolerance rather than meaningful risk management
• Conservative's 'nowhere better to put capital' is a portfolio construction constraint, not a market view; trim proceeds can go to cash, hedges, or diversification
• Both aggressive and conservative analysts miss the middle ground of 15% trim that captures risk management without sacrificing core thesis exposure
• Re-entry framework: 50% on flush to $1,000-$1,062 with RSI below 30, 50% on 50 SMA reclaim on expanding volume, whichever occurs first

→ vs aggressive: False dichotomy between SELL and HOLD; plan to trim only at $1,180 is a phantom trade that may never execute if LLY grinds sideways or tests $1,062 support instead

→ vs aggressive: Sequential EPS dip from $8.26 to $7.94 is being treated as a thesis-breaker when it's actually noise from the heaviest reinvestment phase of a multi-year capacity build

→ vs aggressive: HOLD is not a punt; a balanced 15% trim with stop discipline is an active risk management position that acknowledges the unfavorable setup without abandoning the structural thesis

→ vs conservative: Macro not fully priced: Polymarket shift from 'no cut' to 'hike' would be a discrete new information event compressing multiples further, independent of beta protection

→ vs conservative: Inventory build creates execution risk; $16.79B tied up in working capital alongside $54.9B total debt means meaningful operating leverage to revenue disappointment

→ vs conservative: $1,085 hard stop at lower Bollinger is too tight given March 2026 precedent of multiple sessions testing and closing near the band before reversal; risks whipsawing out of structurally intact position

→ vs conservative: 15% trim is not too aggressive given confluence of technical breakdown, sequential EPS dip, hawkish macro shift, and absent near-term catalyst

→ vs conservative: 'Nowhere to put capital' is portfolio construction rationale disguised as market timing argument; capital can sit in cash, hedge, or diversify rather than being constrained to fully invested equity